Test-system with lysogenic staphylococci model for primary selection of antineoplastic agents
Smolianskaia, A.Z.; Leĭkina, F.I.
Farmakologiia i Toksikologiia 33(4): 479-485
1970
ISSN/ISBN: 0014-8318 PMID: 4261118 Document Number: 19846
Document emailed within 1 workday
Related Documents
Adlakha, S.; Sharma, K.B.; Prakash, K. 1986: Isolation & selection of lysogenic phages for characterization of untypable strains of Salmonella typhimurium isolated in India Indian Journal of Medical Research 84: 7-13Pal, S.; Mukherjea, K.; Bhattacharya, R.; Maity, P. 1997: Pt-ATP as an antineoplastic agent in an experimental mice model system Journal of Experimental and Clinical Cancer Research: Cr 16(3): 255-260
Tokutome, A.; Taniguchi, R.; Maeda, K.; Saito, Y.; Ishii, T.; Minami, S.; Wano, Y.; Ota, T.; Saitoh, H.; Takeda, K. 2018: The Usefulness of a Pamphlet for Preventing Exposure to Antineoplastic Agents at Cancer Patients' Homes and an Awareness Survey for Pharmacists about Providing Information to Cancer Patients about Exposure to Antineoplastic Agents Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(5): 833-839
Shorin, V.A.; Bazhanov, V.S. 1974: Possibility of utilizing lymphatic leukemia L1210 as a first screening model in the primary selection of new antitumor antibiotics Antibiotiki 19(8): 679-684
Biavasco, F.; Giovanetti, E.; Varaldo, P.E. 1991: Selection of resistance to glycopeptide antibiotics in staphylococci Journal of ChemoTherapy 3 Suppl. 1: 166-168
Antczak, K.; Wilczyńska, U. 1980: Selection of a statistical model for the evaluation of the reliability of the results of toxicological analyses. II. Selection of our statistical model for the evaluation Medycyna Pracy 31(6): 453-457
Kayes, J.B. 1973: The effect of surface active-agents on the zeta potential of particles in a model suspension system Journal of Pharmacy and Pharmacology 25: Suppl: 164p
Horáková, L.; Dráber, P.; Nouza, K. 1978: "Nucleolar test" as a system for screening and analysis of immunosuppressive activity of chemical and biological agents Folia Biologica 24(1): 39-50
Mitolo-chieppa, D.; Ceci, A. 1974: Neurotoxicity of some antineoplastic agents Bollettino della Societa Italiana di Biologia Sperimentale 50(17): 1333-1359
Shigeoka, Y.; Shimizu, E. 2007: Myelosuppression due to antineoplastic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 8): 287-293
1971: Chemistry of antineoplastic agents Minerva Medica 62(28): 1492
Aiello, E.; Dattolo, G.; Cirrincione, G.; Almerico, A.M.; Diana, P.; Grimaudo, S.; Mingoia, F.; Barraja, P. 1995: Azolophenanthridines as antineoplastic agents Farmaco 50(6): 365-368
Quaranta, M. 1982: Division of the primary model using the Zeiser system Dental Cadmos 50(12): 17-26
Alieva, E.V. 2003: Experience in the use of a new test system for the rapid indication of the causative agents of campylobacter infection under the conditions of an emergency situation Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 86-88
Berti, T. 1970: Specific histotropism of antineoplastic agents La Clinica Terapeutica 55(4): 293-303
Pettit, G.R.; Srirangam, J.K.; Barkoczy, J.; Williams, M.D.; Boyd, M.R.; Hamel, E.; Pettit, R.K.; Hogan, F.; Bai, R.; Chapuis, J.C.; McAllister, S.C.; Schmidt, J.M. 1998: Antineoplastic agents 365. Dolastatin 10 SAR probes Anti-Cancer Drug Design 13(4): 243-277
Wada, T.; Matsui, H. 2013: Research development of novel antineoplastic agents Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(4): 149
Sokolov, M.V.; Gorodkov, A.Iu. 1985: Quantitative assessment of the reaction of the circulatory system to a test volume load using a mathematical model Anesteziologiia i Reanimatologiia 1985(3): 41-44
Schmoll, H.J.; Hiddemann, W.; Rustum, Y.; Köhne-Wömpner, C.H. 1992: The emerging role for biomodulation of antineoplastic agents Seminars in Oncology 19(2 Suppl 3: 1-3
Kato, T.; Nemoto, R. 1982: Clinical application of microencapsulated antineoplastic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 40(2): 478-488